SCHEMBL29391135

SCHEMBL29391135

N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 5/20 0.39
▸ ENPEP Q07075 3/20 0.36
▸ ECE1 P42892 1/20 0.32
▸ SLC15A2 Q16348 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CA2 P00918 2/20 0.32
▸ GNPAT O15228 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ PLA2G2A P14555 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29374958 0.95 MME (0.36) MMEENPEPGNPAT
SCHEMBL30477912 0.93 MME (0.40) MMEENPEPECE1SLC15A2RECQL
SCHEMBL30859432 0.93 MME (0.40) MMEENPEPECE1SLC15A2RECQL
SCHEMBL29630312 0.93 MME (0.34) MMESLC15A2
SCHEMBL30272502 0.93 MME (0.34) MMESLC15A2
SCHEMBL30477911 0.92 MME (0.39) MMEENPEPECE1SLC15A2RECQL
SCHEMBL29777856 0.92 MME (0.39) MMESLC15A2CA2CA1
SCHEMBL29494071 0.91 MME (0.40) MMEENPEPSLC15A2
SCHEMBL29912491 0.91 MME (0.40) MMEENPEPSLC15A2
Aspartic Acid SCHEMBL4259205 0.91 MME (0.34) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630850-B2 Enzymatic break down of chlorogenic acid in sunflower-containing products CHAPMAN UNIVERSITY (US) 2026-05-19 — — US disclosed
US-20260091118-A1 Methods for Preparation and Use of BacPROTACs for Targeted Protein Degradation in Mycobacteria and Other Bacteria WASHINGTON UNIVERSITY (US) 2026-04-02 — — US disclosed
US-12565666-B2 Methods and compositions for modulating a genome FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) 2026-03-03 — — US disclosed
CN-121574959-A Hydrophilic PET depolymerizing enzyme mutant and application thereof 南京工业大学 2026-02-27 — — CN disclosed
US-20260055137-A1 NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF BETAGRO PUBLIC COMPANY LIMITED (TH) 2026-02-26 — — US disclosed
EP-4638725-A1 CARBOHYDRATE ESTERASE FAMILY 3 (CE3) POLYPEPTIDES HAVING ACETYL XYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME Novozymes A/S (DK) 2025-10-29 — — EP disclosed
US-20250329740-A1 AMINO ACID CONCATEMER SYNERGISTIC SULFUR CONVERSION CATALYST FOR LITHIUM-SULFUR BATTERY AND ITS PREPARATION METHOD AND APPLICATION WENZHOU UNIVERSITY (CN) 2025-10-23 — — US disclosed
US-20250329740-A1 AMINO ACID CONCATEMER SYNERGISTIC SULFUR CONVERSION CATALYST FOR LITHIUM-SULFUR BATTERY AND ITS PREPARATION METHOD AND APPLICATION WENZHOU UNIVERSITY (CN) 2025-10-23 — — US disclosed
US-20250283066-A1 METHODS AND COMPOSITIONS UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2025-09-11 — — US disclosed
WO-2025128568-A1 COMPOSITION AND USE THEREOF FOR INCREASING HEMICELLULOSIC FIBER SOLUBILIZATION NOVOZYMES A/S (DK) 2025-06-19 — — WO disclosed
US-20230016396-A1 METHODS OF POLYPEPTIDE SEQUENCING Encodia, Inc. (US) 2023-01-19 — — US disclosed
WO-2022226109-A1 POLYMER DEGRADING ENZYMES ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2022-10-27 — — WO disclosed
CN-115029332-A Mutant protein of thermophilic PET hydrolase and application thereof 北京化工大学 2022-09-09 — — CN disclosed
EP-4043577-A1 ENANTIOSELECTIVE HYDROLYSIS Technische Universität Graz (AT) 2022-08-17 — — EP disclosed
WO-2022168062-A1 VARIANTS OF HYPERTHERMOPHILIC CARBOXYLESTERASE FOR POLYMER SYNTHESIS UNIVERSIDADE DE COIMBRA (PT) 2022-08-11 — — WO disclosed
WO-2022135988-A1 ENZYMATIC RECYCLING OF POLYURETHANES BY A COMBINATION OF CUTINASES AND LIPASES Société des Produits Nestlé S.A. (CH) 2022-06-30 — — WO disclosed
US-11324216-B2 Methods for controlling root parasitic weeds: inhibitors of seed germination in Striga KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2022-05-10 — — US disclosed
WO-2022084497-A1 ENZYMATIC RECYCLING OF POLYURETHANES BY CUTINASES Société des Produits Nestlé S.A. (CH) 2022-04-28 — — WO disclosed
CN-111540404-B Molecular modification design method for improving catalytic efficiency of prolyl endopeptidase 华东师范大学 2022-04-22 — — CN disclosed
CN-111763697-B Medium-long carbon chain triglyceride edible oil and preparation method thereof 成都天一美膳营养食品有限公司 2022-02-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630850-B2 Enzymatic break down of chlorogenic acid in sunflower-containing products LCT, TYR, CEL MME 1574/4885ENPEP 286/4885ECE1 1687/4885
US-20260055137-A1 NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF VIP, ARGLU1, PELP1 MME 904/4885ENPEP 56/4885ECE1 1494/4885
US-20250283066-A1 METHODS AND COMPOSITIONS TRMT1, TARBP1, RNGTT MME 941/4885ENPEP 45/4885ECE1 3648/4885
US-20260091118-A1 Methods for Preparation and Use of BacPROTACs for Targeted Protein Degradation in Mycobacteria and Other Bacteria CLPP, DNPEP, NPEPPS MME 382/4885ENPEP 14/4885ECE1 2158/4885
US-11324216-B2 Methods for controlling root parasitic weeds: inhibitors of seed germination in Striga CROCC, PTPRG, GRIK5 MME 1641/4885ENPEP 2225/4885ECE1 3483/4885
US-12565666-B2 Methods and compositions for modulating a genome RPRD2, ERN2, TPR MME 1137/4885ENPEP 1624/4885ECE1 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback